Abstract
Background Multivariable Mendelian randomization (MVMR) is a statistical approach using genetic variants as instrumental variables to estimate direct causal effects of multiple exposures on an outcome simultaneously. In univariable MR findings are typically illustrated through plots created using summary data from genome-wide association studies (GWAS), yet analogous plots for MVMR have so far been unavailable due to the multidimensional nature of the analysis.
Methods We propose a radial formulation of MVMR, and an adapted Galbraith radial plot, which allows for the direct effect of each exposure within an MVMR analysis to be visualised. Radial MVMR plots facilitate the detection of outlier variants, indicating violations of one or more assumptions of MVMR. In addition, the RMVMR R package is presented as accompanying software for implementing the methods described.
Results We demonstrate the effectiveness of the radial MVMR approach through simulations and applied analyses, estimating the effect of lipid fractions on coronary heart disease (CHD). We find evidence of a protective effect of high-density lipoprotein (HDL) and a positive effect of low-density lipoprotein (LDL) on CHD, however, the protective effect of HDL appeared to be smaller in magnitude when removing outlying variants. In combination with simulated examples, we highlight how important features of MVMR analyses can be explored using a range of tools incorporated within the RMVMR R package.
Conclusions Radial MVMR effectively visualises causal effect estimates, and provides valuable diagnostic information with respect to the underlying assumptions of MVMR.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by The Wellcome Trust (108902/B/15/Z) and UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/2, MC_UU_00011/1).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study only uses simulated data and publicly available summary data from genome-wide association studies, available at https://gwas.mrcieu.ac.uk/.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* wes.spiller{at}bristol.ac.uk
Data Availability
This study only uses simulated data and publicly available summary data from genome-wide association studies. Scripts for replicating the analyses and summary GWAS data used for applied analyses are provided at https://github.com/WSpiller/RMVMR_Analyses.
